Prognostic role of CIP2A expression in serous ovarian cancer
2011 · British Journal of Cancer · 102 citations
https://doi.org/10.1038/bjc.2011.346
C
Camilla Böckelman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
2.0K
Citations
25
h-index
37
i10-index
Camilla Böckelman is an academic researcher from University of Helsinki. The author has contributed to research in topics: Genetic factors in colorectal cancer & PARP inhibition in cancer therapy & Peptidase Inhibition and Analysis. The author has an h-index of 25, co-authored 103 publications.
ORCID: 0000-0002-1628-0305Papers by this author
worksEvaluation of toll-like receptors as prognostic biomarkers in gastric cancer: high tissue TLR5 predicts a better outcome
2019 · Scientific Reports · 49 citations
https://doi.org/10.1038/s41598-019-49111-2
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel
2021 · Scientific Reports · 38 citations
https://doi.org/10.1038/s41598-020-80785-1
The prognostic role of tissue TLR2 and TLR4 in colorectal cancer
2020 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 35 citations
https://doi.org/10.1007/s00428-020-02833-5
A comparative study of two PODXL antibodies in 840 colorectal cancer patients
2014 · BMC Cancer · 14 citations
https://doi.org/10.1186/1471-2407-14-494
Systemic inflammatory response in colorectal cancer is associated with tumour mismatch repair and impaired survival
2024 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-024-80803-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat